Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols.

Jakovljevic, M; Gutzwiller, F S; Schwenkglenks, M; Milovanovic, O; Rancic, N; Varjacic, M; Stojadinovic, D; Dagovic, A; Matter-Walstra, K.

Afiliação

Jakovljevic M; The Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia and Montenegro.
Gutzwiller FS; University of Basel, Basel, Switzerland.
Schwenkglenks M; University of Basel, Basel, Switzerland.
Milovanovic O; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia and Montenegro.
Rancic N; Military Medical Academy University of Defence Belgrade, Belgrade, Serbia and Montenegro.
Varjacic M; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia and Montenegro.
Stojadinovic D; Urology Clinic, University Clinical Center Kragujevac, Kragujevac, Serbia and Montenegro.
Dagovic A; Oncology and Radiation Therapy Center, Clinical Center Kragujevac, Kragujevac, Serbia and Montenegro.
Matter-Walstra K; University of Basel, Basel, Switzerland.

Value Health ; 17(7): A629, 2014 Nov.

Article em En | MEDLINE | ID: mdl-27202230

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article